Revvity
Emily Feldman is a scientist at Revvity on the Research Reagents R&D team in Lafayette, Colorado, where she supports Horizon Discovery and Dharmacon products and services. Her education focused on non-coding RNA biology, molecular virology, and functional genomics, while her early career has a main theme of nuclease reagent development.
Disclosure information not submitted.
CRISPR workflow for increased efficacy in CAR-T engineering and screening
Monday, February 5, 2024
3:00 PM – 3:20 PM EST